Shareholders' Deficit (Tables)
|
9 Months Ended |
12 Months Ended |
Sep. 30, 2021 |
Dec. 31, 2020 |
Stockholders' Equity Note [Abstract] |
|
|
Schedule of redemption period |
|
Redemption
Period |
|
Redemption
Percentage |
1. The period beginning on the date of the issuance of shares of Series A Preferred Stock and ending on the date which is sixty days following the Issuance Date. |
|
|
100% |
2. The period beginning on the date that is sixty-one days from the Issuance Date and ending ninety days following the Issuance Date. |
|
|
107% |
3. The period beginning on the date that is ninety-one days from the Issuance Date and ending one hundred twenty days following the Issuance Date. |
|
|
112% |
4. The period beginning on the date that is one hundred twenty-one days from the Issuance Date and ending one hundred fifty days following the Issuance Date. |
|
|
117% |
5. The period beginning on the date that is one hundred fifty-one days from the Issuance Date and ending one hundred eighty days following the Issuance Date. |
|
|
120% |
|
Schedule of nonvested activity |
|
|
Number of
Non-Vested Shares |
|
|
Weighted
Average Grant Date Fair Value |
|
Non-vested,
December 31, 2020 |
|
|
23,826,926 |
|
|
$ |
0.16 |
|
Granted |
|
|
6,194,767 |
|
|
|
0.06 |
|
Forfeited |
|
|
(700,000 |
) |
|
|
(0.07 |
) |
Shares
vested |
|
|
(15,051,573 |
) |
|
|
(0.14 |
) |
Non-vested,
September 30, 2021 |
|
|
14,270,120 |
|
|
$ |
0.14 |
|
|
|
|
Number
of Non-vested
Shares
|
|
|
Weighted
Average Grant Date Fair Value |
|
Non-vested, December 31, 2018 |
|
|
5,998,672 |
|
|
$ |
0.61 |
|
Granted |
|
|
12,000,000 |
|
|
|
0.05 |
|
Forfeited |
|
|
(323,373 |
) |
|
|
(0.59 |
) |
Non-vested, December 31, 2019 |
|
|
17,675,299 |
|
|
|
0.23 |
|
Granted |
|
|
7,450,000 |
|
|
|
0.04 |
|
Shares vested |
|
|
(1,298,373 |
) |
|
|
(0.41 |
) |
Non-vested, December 31, 2020 |
|
|
23,826,926 |
|
|
$ |
0.16 |
|
|
Schedule of stock option activities |
|
|
Number
of Options |
|
|
Weighted
Average Exercise Price |
|
|
Weighted
Average Remaining Contractual Term (Years) |
|
|
Aggregate
Intrinsic
Value |
|
Balance
Outstanding, December 31, 2020 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
5.10 |
|
|
$ |
48,000 |
|
Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Forfeited |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance
Outstanding, September 30, 2021 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
4.33 |
|
|
$ |
2,160 |
|
Exercisable,
September 30, 2021 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
4.33 |
|
|
$ |
2,160 |
|
|
|
|
Number
of Options |
|
|
Weighted
Average Exercise Price |
|
|
Weighted
Average Remaining Contractual Term (Years) |
|
|
Aggregate
Intrinsic Value |
|
Balance Outstanding, December 31, 2018 |
|
|
11,445,698 |
|
|
$ |
0.30 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(3,000,000 |
) |
|
|
0.03 |
|
|
|
|
|
|
|
|
|
Balance Outstanding, December 31, 2019 |
|
|
8,445,698 |
|
|
|
0.40 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
Balance Outstanding, December 31, 2020 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
5.10 |
|
|
$ |
48,000 |
|
Exercisable, December 31, 2020 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
5.10 |
|
|
$ |
48,000 |
|
|
Schedule of warrant activities |
|
|
Number
of Warrants |
|
|
Weighted
Average Exercise Price |
|
|
Weighted
Average Remaining Contractual Term (Years) |
|
|
Aggregate
Intrinsic Value |
|
Balance
Outstanding December 31, 2020 |
|
|
2,050,000 |
|
|
$ |
0.05 |
|
|
|
3.66 |
|
|
$ |
137,000 |
|
Exercised |
|
|
(1,050,000 |
) |
|
|
0.01 |
|
|
|
- |
|
|
|
- |
|
Cancelled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance
Outstanding September 30, 2021 |
|
|
1,000,000 |
|
|
$ |
0.09 |
|
|
|
2.80 |
|
|
$ |
- |
|
Exercisable,
September 30, 2021 |
|
|
1,000,000 |
|
|
$ |
0.09 |
|
|
|
2.80 |
|
|
$ |
- |
|
|
|
|
Number
of Warrants |
|
|
Weighted
Average Exercise Price |
|
|
Weighted
Average Remaining Contractual Term (Years) |
|
|
Aggregate
Intrinsic Value |
|
Balance Outstanding December 31, 2018 |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
|
$ |
- |
|
Granted |
|
|
2,050,000 |
|
|
|
0.10 |
|
|
|
|
|
|
|
|
|
Cancelled |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
Balance Outstanding December 31, 2019 |
|
|
2,050,000 |
|
|
$ |
0.10 |
|
|
|
4.66 |
|
|
$ |
4,400 |
|
Granted |
|
|
288,750 |
|
|
|
0.10 |
|
|
|
|
|
|
|
|
|
Cancelled |
|
|
(288,750 |
) |
|
|
(0.10 |
) |
|
|
|
|
|
|
|
|
Exercisable, December 31, 2020 |
|
|
2,050,000 |
|
|
$ |
0.05 |
|
|
|
3.66 |
|
|
$ |
137,000 |
|
|